Viveon Health Acquisition Corp.
AMEX:VHAQ
11.3 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0.269 | 0.099 | 0.203 | 0.171 | 0.284 | 1.05 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | -0.269 | -0.099 | -0.203 | -0.171 | -0.284 | -1.05 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0.301 | -0.513 | 0.704 | 0.436 | 0.742 | 1.1 | 0.789 | 0.648 | 0.321 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0.269 | 0 | 0 | 0 | 0 | -0.789 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0 | 0 | 0.57 | -0.513 | 0.704 | 0.436 | 0.742 | 1.1 | 0.789 | 0.648 | 0.321 | 0 | 0 |
| Other Expenses
| 0 | 0 | 0 | -0.133 | 0.236 | 0.203 | 0.332 | 0.789 | -1.577 | 0 | 0 | -0.026 | 0 |
| Operating Expenses
| 0 | 0 | 0.054 | -0.282 | 0.94 | 0.639 | 1.074 | 2.348 | 0.789 | 0.648 | 0.321 | -0.026 | 0 |
| Operating Income
| 0 | 0 | -0.596 | 0.282 | -0.94 | -0.639 | -1.074 | -2.348 | -0.789 | -0.648 | -0.321 | -0.026 | -0 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0 | 0 | 0.759 | 2.728 | -1.445 | 1.114 | -0.45 | 0.49 | 1.854 | 1.694 | 3.917 | 0 | 0 |
| Income Before Tax
| 0 | 0 | 0.163 | 3.009 | -2.385 | 0.474 | -1.524 | -1.858 | 1.176 | -0.409 | 3.581 | -0.026 | -0 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.1 | 2.213 | 1.445 | -1.114 | 0.45 | -0.686 | -3.733 | -0.005 | -0.005 | -0.055 | 0 |
| Net Income
| 0 | 0 | 0.263 | 2.948 | -3.83 | 1.588 | -1.974 | -1.858 | 1.176 | -0.409 | 3.581 | -0.026 | -0 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0 | 0 | 0.045 | 0.43 | -0.42 | 0.18 | -0.09 | -0.092 | 0.049 | -0.017 | 0.15 | -0.004 | -0 |
| EPS Diluted
| 0 | 0 | 0.045 | 0.43 | -0.42 | 0.18 | -0.09 | -0.077 | 0.049 | -0.017 | 0.15 | -0.004 | -0 |
| EBITDA
| 0 | 0 | -0.596 | 1.417 | -1.445 | -1 | -1.424 | -2.348 | -2.748 | -0.648 | -4.219 | -0.026 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |